Osaic Holdings’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Osaic Holdings’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,121	Closed	-$4.71K	–	7742
2023 Q1	$4.71K	Buy	1,121 +100	+10%	+$519	﹤0.01%	6350
2022 Q4	$6K	Buy	1,021 +1,000	+4,762%	+$5.46K	﹤0.01%	6246
2022 Q3	$0	Sell	21 -1	-5%	-$6	﹤0.01%	7817
2022 Q2	$0	Sell	22 -10,627	-100%	-$54.4K	﹤0.01%	7900
2022 Q1	$50K	Hold	10,649	–	–	﹤0.01%	5097
2021 Q4	$26K	Sell	10,649 -500	-4%	-$1.22K	﹤0.01%	5632
2021 Q3	$32K	Buy	11,149 +468	+4%	+$1.27K	﹤0.01%	5454
2021 Q2	$27K	Hold	10,681	–	–	﹤0.01%	5482
2021 Q1	$31K	Buy	10,681 +9,878	+1,230%	+$32.2K	﹤0.01%	5220
2020 Q4	$2K	Hold	803	–	–	﹤0.01%	6156
2020 Q3	$2K	Hold	803	–	–	﹤0.01%	5951
2020 Q2	$1K	Sell	803 -340	-30%	-$359	﹤0.01%	6066
2020 Q1	$1K	Buy	+1,143	New	+$1.31K	﹤0.01%	6022

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Osaic Holdings's CTIC Position: Q2 2023 in Review

Osaic Holdings sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 1,121 shares — an estimated $4.71K sold.

Osaic Holdings first reported a position in CTIC in Q1 2020 and held it in 13 quarters. The position peaked at $50K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Osaic Holdings reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 1,121 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $4.71K.
Osaic Holdings first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2020 and held it in 13 quarters.
Osaic Holdings's CTI BioPharma Corp. (DE) Common Stock position peaked at $50K in Q1 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.